Found: 43
Select item for more details and to access through your institution.
Expanding the molecular spectrum of gene fusions in endometrial stromal sarcoma: Novel subunits of the chromatin remodeling complexes PRC2 and NuA4/TIP60 as alternative fusion partners.
- Published in:
- Genes, Chromosomes & Cancer, 2023, v. 62, n. 3, p. 152, doi. 10.1002/gcc.23109
- By:
- Publication type:
- Article
Assigning evidence to actionability: An introduction to variant interpretation in precision cancer medicine.
- Published in:
- Genes, Chromosomes & Cancer, 2022, v. 61, n. 6, p. 303, doi. 10.1002/gcc.22987
- By:
- Publication type:
- Article
KRAS/GNAS‐testing by highly sensitive deep targeted next generation sequencing improves the endoscopic ultrasound‐guided workup of suspected mucinous neoplasms of the pancreas.
- Published in:
- Genes, Chromosomes & Cancer, 2021, v. 60, n. 7, p. 489, doi. 10.1002/gcc.22946
- By:
- Publication type:
- Article
NTRK testing: First results of the QuiP‐EQA scheme and a comprehensive map of NTRK fusion variants and their diagnostic coverage by targeted RNA‐based NGS assays.
- Published in:
- Genes, Chromosomes & Cancer, 2020, v. 59, n. 8, p. 445, doi. 10.1002/gcc.22853
- By:
- Publication type:
- Article
Immuno‐oncology gene expression profiling of formalin‐fixed and paraffin‐embedded clear cell renal cell carcinoma: Performance comparison of the NanoString nCounter technology with targeted RNA sequencing.
- Published in:
- Genes, Chromosomes & Cancer, 2020, v. 59, n. 7, p. 406, doi. 10.1002/gcc.22843
- By:
- Publication type:
- Article
Testing NTRK testing: Wet‐lab and in silico comparison of RNA‐based targeted sequencing assays.
- Published in:
- Genes, Chromosomes & Cancer, 2020, v. 59, n. 3, p. 178, doi. 10.1002/gcc.22819
- By:
- Publication type:
- Article
Next generation sequencing of the cellular and liquid fraction of pancreatic cyst fluid supports discrimination of IPMN from pseudocysts and reveals cases with multiple mutated driver clones: First findings from the prospective ZYSTEUS biomarker study.
- Published in:
- Genes, Chromosomes & Cancer, 2019, v. 58, n. 1, p. 3, doi. 10.1002/gcc.22682
- By:
- Publication type:
- Article
Targeted deep sequencing of effusion cytology samples is feasible, informs spatiotemporal tumor evolution, and has clinical and diagnostic utility.
- Published in:
- Genes, Chromosomes & Cancer, 2018, v. 57, n. 2, p. 70, doi. 10.1002/gcc.22509
- By:
- Publication type:
- Article
Targeted next-generation sequencing enables reliable detection of HER2 (ERBB2) status in breast cancer and provides ancillary information of clinical relevance.
- Published in:
- Genes, Chromosomes & Cancer, 2017, v. 56, n. 4, p. 255, doi. 10.1002/gcc.22431
- By:
- Publication type:
- Article
Synonymous EGFR variant p.Q787Q is neither prognostic nor predictive in patients with lung adenocarcinoma.
- Published in:
- Genes, Chromosomes & Cancer, 2017, v. 56, n. 3, p. 214, doi. 10.1002/gcc.22427
- By:
- Publication type:
- Article
Tubular, lactating, and ductal adenomas are devoid of MED12 Exon2 mutations, and ductal adenomas show recurrent mutations in GNAS and the PI3K-AKT pathway.
- Published in:
- Genes, Chromosomes & Cancer, 2017, v. 56, n. 1, p. 11, doi. 10.1002/gcc.22396
- By:
- Publication type:
- Article
Histological and molecular plasticity of ALK-positive non-small-cell lung cancer under targeted therapy: a case report.
- Published in:
- 2022
- By:
- Publication type:
- Case Study
Nivolumab and ipilimumab in recurrent or refractory cancer of unknown primary: a phase II trial.
- Published in:
- Nature Communications, 2023, v. 14, n. 1, p. 1, doi. 10.1038/s41467-023-42400-5
- By:
- Publication type:
- Article
Deficiency in DNA Damage Repair Proteins Promotes Prostate Cancer Cell Migration through Oxidative Stress.
- Published in:
- Onco, 2024, v. 4, n. 2, p. 56, doi. 10.3390/onco4020005
- By:
- Publication type:
- Article
De Novo Versus Secondary Metastatic EGFR -Mutated Non-Small-Cell Lung Cancer.
- Published in:
- Frontiers in Oncology, 2021, v. 11, p. N.PAG, doi. 10.3389/fonc.2021.640048
- By:
- Publication type:
- Article
Combination of Crizotinib and Osimertinib in T790M+ EGFR-Mutant Non-Small Cell Lung Cancer with Emerging MET Amplification Post-Osimertinib Progression in a 10-Year Survivor: A Case Report.
- Published in:
- Case Reports in Oncology, 2021, v. 14, n. 1, p. 477, doi. 10.1159/000513904
- By:
- Publication type:
- Article
Real-world implementation of sequential targeted therapies for EGFR-mutated lung cancer.
- Published in:
- Therapeutic Advances in Medical Oncology, 2021, p. 1, doi. 10.1177/1758835921996509
- By:
- Publication type:
- Article
Surface expression and genotypes of Toll-like receptors 2 and 4 in patients with juvenile idiopathic arthritis and systemic lupus erythematosus.
- Published in:
- Pediatric Rheumatology, 2013, v. 11, n. 1, p. 1, doi. 10.1186/1546-0096-11-9
- By:
- Publication type:
- Article
KRAS and TP53 co-mutation predicts benefit of immune checkpoint blockade in lung adenocarcinoma.
- Published in:
- British Journal of Cancer, 2024, v. 131, n. 3, p. 524, doi. 10.1038/s41416-024-02746-z
- By:
- Publication type:
- Article
Genomic architecture of FGFR2 fusions in cholangiocarcinoma and its implication for molecular testing.
- Published in:
- 2022
- By:
- Publication type:
- journal article
Integrated genotype–phenotype analysis of familial adenomatous polyposis-associated hepatocellular adenomas.
- Published in:
- Virchows Archiv: European Journal of Pathology, 2024, v. 484, n. 4, p. 587, doi. 10.1007/s00428-023-03680-w
- By:
- Publication type:
- Article
Erratum zu: Varianteninterpretation in dermolekularen Pathologie und Onkologie.
- Published in:
- 2021
- By:
- Publication type:
- Correction Notice
Varianteninterpretation in der molekularen Pathologie und Onkologie: Eine Einführung.
- Published in:
- Der Pathologe, 2021, v. 42, n. 4, p. 369, doi. 10.1007/s00292-021-00938-5
- By:
- Publication type:
- Article
Genomic heterogeneity at baseline is associated with T790M resistance mutations in EGFR‐mutated lung cancer treated with the first‐/second‐generation tyrosine kinase inhibitors.
- Published in:
- Journal of Pathology: Clinical Research, 2024, v. 10, n. 2, p. 1, doi. 10.1002/cjp2.354
- By:
- Publication type:
- Article
First proficiency testing for NGS‐based and combined NGS‐ and FISH‐based detection of FGFR2 fusions in intrahepatic cholangiocarcinoma.
- Published in:
- Journal of Pathology: Clinical Research, 2023, v. 9, n. 2, p. 100, doi. 10.1002/cjp2.308
- By:
- Publication type:
- Article
miRNA profiling of biliary intraepithelial neoplasia reveals stepwise tumorigenesis in distal cholangiocarcinoma via the miR‐451a/ATF2 axis.
- Published in:
- Journal of Pathology, 2020, v. 252, n. 3, p. 239, doi. 10.1002/path.5514
- By:
- Publication type:
- Article
Real-world implementation of sequential targeted therapies for EGFR-mutated lung cancer.
- Published in:
- Therapeutic Advances in Medical Oncology, 2021, p. 1, doi. 10.1177/1758835921996509
- By:
- Publication type:
- Article
Targetable ERBB2 mutations identified in neurofibroma/schwannoma hybrid nerve sheath tumors.
- Published in:
- 2020
- By:
- Publication type:
- journal article
BAP1 and PTEN mutations shape the immunological landscape of clear cell renal cell carcinoma and reveal the intertumoral heterogeneity of T cell suppression: a proof-of-concept study.
- Published in:
- Cancer Immunology, Immunotherapy, 2023, v. 72, n. 6, p. 1603, doi. 10.1007/s00262-022-03346-7
- By:
- Publication type:
- Article
Deciphering the immunosuppressive tumor microenvironment in ALK- and EGFR-positive lung adenocarcinoma.
- Published in:
- Cancer Immunology, Immunotherapy, 2022, v. 71, n. 2, p. 251, doi. 10.1007/s00262-021-02981-w
- By:
- Publication type:
- Article
Digital Spatial Profiling Identifies the Tumor Periphery as a Highly Active Biological Niche in Clear Cell Renal Cell Carcinoma.
- Published in:
- Cancers, 2023, v. 15, n. 20, p. 5050, doi. 10.3390/cancers15205050
- By:
- Publication type:
- Article
RNA-Based Detection of Gene Fusions in Formalin-Fixed and Paraffin-Embedded Solid Cancer Samples.
- Published in:
- Cancers, 2019, v. 11, n. 9, p. 1309, doi. 10.3390/cancers11091309
- By:
- Publication type:
- Article
Detection of TP53 Mutations in Tissue or Liquid Rebiopsies at Progression Identifies ALK+ Lung Cancer Patients with Poor Survival.
- Published in:
- Cancers, 2019, v. 11, n. 1, p. 124, doi. 10.3390/cancers11010124
- By:
- Publication type:
- Article
Integrated clinicomolecular characterization identifies RAS activation and CDKN2A deletion as independent adverse prognostic factors in cancer of unknown primary.
- Published in:
- International Journal of Cancer, 2020, v. 146, n. 11, p. 3053, doi. 10.1002/ijc.32882
- By:
- Publication type:
- Article
Variant classification in precision oncology.
- Published in:
- International Journal of Cancer, 2019, v. 145, n. 11, p. 2996, doi. 10.1002/ijc.32358
- By:
- Publication type:
- Article
Comparative genetic profiling aids diagnosis and clinical decision making in challenging cases of CUP syndrome.
- Published in:
- International Journal of Cancer, 2019, v. 145, n. 11, p. 2963, doi. 10.1002/ijc.32316
- By:
- Publication type:
- Article
Combined targeted DNA and RNA sequencing of advanced NSCLC in routine molecular diagnostics: Analysis of the first 3,000 Heidelberg cases.
- Published in:
- International Journal of Cancer, 2019, v. 145, n. 3, p. 649, doi. 10.1002/ijc.32133
- By:
- Publication type:
- Article
Measurement of tumor mutational burden (TMB) in routine molecular diagnostics: in silico and real‐life analysis of three larger gene panels.
- Published in:
- International Journal of Cancer, 2019, v. 144, n. 9, p. 2303, doi. 10.1002/ijc.32002
- By:
- Publication type:
- Article
Size matters: Dissecting key parameters for panel‐based tumor mutational burden analysis.
- Published in:
- International Journal of Cancer, 2019, v. 144, n. 4, p. 848, doi. 10.1002/ijc.31878
- By:
- Publication type:
- Article
Three molecular pathways model colorectal carcinogenesis in Lynch syndrome.
- Published in:
- International Journal of Cancer, 2018, v. 143, n. 1, p. 139, doi. 10.1002/ijc.31300
- By:
- Publication type:
- Article
<italic>EML4‐ALK</italic> fusion variant V3 is a high‐risk feature conferring accelerated metastatic spread, early treatment failure and worse overall survival in ALK<sup>+</sup> non‐small cell lung cancer.
- Published in:
- International Journal of Cancer, 2018, v. 142, n. 12, p. 2589, doi. 10.1002/ijc.31275
- By:
- Publication type:
- Article
Precision oncology based on omics data: The NCT Heidelberg experience.
- Published in:
- International Journal of Cancer, 2017, v. 141, n. 5, p. 877, doi. 10.1002/ijc.30828
- By:
- Publication type:
- Article
Next-generation sequencing facilitates detection of the classic E13-A20 EML4-ALK fusion in an ALK-FISH/IHC inconclusive biopsy of a stage IV lung cancer patient: a case report.
- Published in:
- 2016
- By:
- Publication type:
- Case Study